Crossing Borders for Care: How Poland Joins Spain and France in the New Era of European Medical Tourism

Crossing Borders for Care: How Poland Joins Spain and France in the New Era of European Medical Tourism

Crossing Borders for Care: How Poland Joins Spain and France in the New Era of European Medical Tourism

In recent years, the landscape of European travel has been quietly altered by a practical, albeit taxing, necessity: the search for affordable and accessible medicine. From the sun-soaked borders of Spain and France to the forested borders of Lithuania and Belarus, a new type of “medical tourism” has emerged. This trend is driven not only by a desire for luxury wellness retreats but also by systemic shortages of rare medications and undeniable pressure to cut personal healthcare costs. What was once a leisure trip has become, for many, a logistical mission to obtain life-saving treatments that are either unavailable or prohibitively expensive in their home countries.

Legal Shakes-ups and the End of Advertising Bans

The regulatory environment governing this sector is currently undergoing a massive shift. Significant EU reforms have been sparked by a landmark case involving Poland at the bloc’s highest court, with the ultimate goal of equalizing medicine access across all member states. For over fourteen years, a blanket ban on pharmacy advertising was maintained by the Polish government. However, on June 19, 2025, it was ruled by the Court of Justice of the European Union (CJEU) that such an absolute prohibition went too far. It was determined by the judges that the restriction breached EU law by limiting the freedom of establishment and the free provision of services within the single market. Consequently, the advertising landscape for pharmacies is being redesigned, a move that is viewed with a mixture of optimism and concern by healthcare professionals who fear the commercialization of essential medicine.

The Risks of Self-Diagnosis and Digital Health

The importance of modern technology and vaccinations in extending human life is universally acknowledged, yet the sector is frequently plagued by misinformation. Concern has been raised regarding the spread of conspiracy theories, including unsubstantiated claims regarding common painkillers and developmental disorders. Furthermore, the dangers of self-diagnosis are being highlighted by health authorities. It is admitted by more than half of the Spanish population that the internet is used to self-diagnose symptoms, while in the Czech Republic, this figure is reported to be as high as 95 per cent. Such practices are considered dangerous, as the complexities of proper dosage and the risk of unlisted drug interactions are often overlooked when professional medical advice is bypassed.

Navigating the Map of Medicine Shortages

The reality of drug shortages is felt acutely across the continent. It has been noted by industry leaders in the pharmaceutical sector that decades may be required before the production of active substances in Europe reaches a satisfactory scale again. This scarcity is further complicated by a patchwork of differing national regulations. Even within the harmonized framework of the EU, certain substances may be permitted in one nation while being strictly prohibited in another. For instance, stories were documented of travellers moving between France and Spain to acquire tyrothricin—an antimicrobial peptide that was available over-the-counter in Spain but banned in France. Conversely, vaccines for tick-borne diseases have been sought by Spaniards in France when local supplies were exhausted.

The Balkan and Baltic Corridors

In Eastern Europe, the struggle for medication is particularly pronounced. A chronic shortage of essential drugs has been battled by Bulgaria for years, leading citizens to seek anti-epileptic and diabetes medications in neighbouring Greece, Turkey, and Serbia. Often, these journeys are undertaken not just for availability, but for the significantly lower prices found in Turkish pharmacies. Similarly, in the Baltic region, medicines are frequently brought into Lithuania from Poland and Belarus. In some instances, a misconception is held by locals that Belarusian products are more effective, though strict limits are enforced by Lithuanian customs—specifically, no more than ten packages per person may be imported at one time to prevent illegal resale.

Legal Requirements for the Medical Traveller

For those planning to transport medication across borders, several legal hurdles must be cleared. It is advised by the Polish Patients Ombudsman that medicines may be transported for personal use only, provided they are intended for medical purposes. Travellers are encouraged to carry official documentation confirming their medical need for the substances. Furthermore, it must be verified whether the specific medications are permitted for export by the diplomatic missions or institutions of the departure country. The seizure of goods is a common consequence for those who exceed the allowed quantities or fail to provide the necessary paperwork.

The Future: The EU Pharmaceutical Package

Hope for a more balanced future is being placed in the “EU Pharmaceutical Package”, which represents the most significant reform of medicine laws in twenty years. EU authorities intend to create a single market for medicines to ensure that every patient has safe, affordable, and equal access, regardless of where they live. This reform aims to prevent shortages and improve supply chain security. However, the public will need to be patient, as the tangible effects of these changes, such as shorter wait times and updated patent rules, are not expected until at least 2028. Until then, the paths between Europe’s pharmacies are well-travelled by modern medical tourists.

The post Crossing Borders for Care: How Poland Joins Spain and France in the New Era of European Medical Tourism appeared first on Travel And Tour World.